What Makes IsoMedica Different?
Building a Complete
Medical Isotope Supply Chain
From recovering valuable radioisotopes from mining and industrial waste streams to advanced purification and commercial production, entX is building an integrated medical isotope capability in South Australia.

OTher Projects
entX is combining feedstock access, proprietary purification technology and dedicated production infrastructure to develop an integrated medical isotope supply capability in South Australia.
Reliable medical isotope supply requires more than access to raw materials. It takes control over feedstock, specialised extraction and purification technology, and the infrastructure to deliver high-purity isotopes at commercial scale.
Through IsoMedica, entX is bringing these capabilities together, creating a differentiated position in the growing radiopharmaceutical and targeted alpha therapy markets.
Three Key Differentiators
1. Feedstock Control: From Mines to Medicines
entX is developing access to medically useful radioisotopes from mining and industrial waste streams through strategic partnerships. This Mines to Medicines approach transforms potential waste liabilities into valuable feedstock for medical applications, creating benefits for both the resource and healthcare sectors.
2. Proprietary Extraction and Purification Technology
entX has spent several years developing and validating its radium and thorium extraction and purification processes. In early 2025, the team successfully isolated and extracted commercial quantities of thorium-228 from waste materials through its first demonstration at scale. Thorium-228 is a precursor to lead-212, an important radioisotope in targeted alpha therapy.
3. Dedicated Medical Isotope Production Infrastructure
Through IsoMedica, entX is developing the specialised facilities, licensing, radiation safety systems and operational capabilities required for end-to-end medical isotope production. The objective is to establish Australia's first dedicated alpha therapy isotope manufacturing facility.
An Integrated Capability in South Australia
By bringing feedstock access, proprietary technology and dedicated production infrastructure together, entX is developing an integrated medical isotope supply platform designed to support more secure and reliable isotope supply.
Combining South Australia's established resources and healthcare capabilities, the Mines to Medicines model provides a distinctive foundation for entX's ambitions in the global medical isotope market.
